CECOG Academy
T

Personalized Treatment Approach by Molecular Profiling Might Lead to Better Prognosis of mPDAC Patients

By CECOG Academy FEATURING Talia Golan
By CECOG Academy FEATURING Talia Golan
52 views
September 6, 2022
0 Comments
Login to view comments. Click here to Login

Featured Video

20:00
Exelixis

Child-Pugh Classification and its Role in Treatment Decisions in Pat…

Feat. P. Gholam

Featured Video

15:07
Exelixis

Safety and Efficacy Data of a TKI Monotherapy in HCC

Feat. J. Mizrahi

Related Content

AUTOPLAY
46:37
Albert Einstein College of Medicine

Screening for Pancreatic Cancer

Feat. A. L. Lucas
27:37
ASCO GI 2023 Conference Coverage

ASCO GI 2023 Expert Panel Discussion: Practice-Changing Updates

Feat. N. Uboha, A. Turk, K. Spencer, M. Cecchini
23:58
ASCO GI 2023 Conference Coverage

ASCO GI 2023 Key Studies

Feat. R. Kim, R. Mehta
20:07
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Summary: "GI Expert Panel Discussion on Key Trials I…

Feat. Y. Janjigian, S. Cytryn, S. Maron
53:40
Philadelphia County Medical Society

Current Status for the Early Detection of Pancreatic Cancer

Feat. R. Brand
03:50
UCLA Health

Perspectives on the Recent FDA Approval of NALIRIFOX in Frontline Me…

Feat. Z. Wainberg
12:08
Yale Cancer Center

GI Oncology Year in Review: Precision Medicine Update in Metastatic …

Feat. J. Lacy
07:53
Total Health

Updates on Pancreatic Cancer - 2023 ASCO® Direct Philadelphia

Feat. D. Lin
06:28
Shubham Pant

FDA Approval of Liposomal Irinotecan/NALIRIFOX in 1L Metastatic Panc…

10:53
Yale Cancer Center

GI Oncology Year in Review: Metastatic Pancreatic Cancer - NAPOLI-3 …

Feat. J. Lacy
18:35
Rachna Shroff

Augmenting Standard Treatment Options in Pancreatic Cancer

15:57
Rush University Medical Center

Precision Medicine in Pancreatic Cancer: Treatment to Screening

Feat. F. Bishehsari
09:11
Insights from 2024 ASCO® GI Annual Meeting

ASCO® GI 2024 Insights: "Evaluating Novel Therapies and ctDNA a…

Feat. R. Mukherji
06:16
ecancer

ASCO® 2023 Insights: "NAPOLI 3 Analysis of 1L NALIRIFOX vs. Gem…

Feat. E. O’Reilly
28:39
MUSC Health

Precision Medicine in Pancreatic Cancer and the Emerging Role of Gls

Feat. F. Bishehsari
10:41
ASCO GI 2023 Conference Coverage

ASCO GI 2023 NAPOLI-3 Randomized, Open-Label Phase 3 Study: Liposoma…

Feat. Z. Wainberg
08:03
Insights from 2023 ESMO World Congress on Gastrointestinal Cancer Annual Meeting

2023 ESMO WCGIC Insights: "Additional Results From the Phase 3 …

Feat. Z. Wainberg
23:32
The University of Kansas Cancer Center

Updates on Pancreatic Cancer Treatment

Feat. A. Kasi
29:00
Total Health

Disparities Through GI Cancers: Panel Discussion

Feat. R. Kim, J. Starr
09:16
Total Health

Clinical Implications & Highlights of Recent Pancreatic Cancer T…

Feat. J. Kratz